HEADER IMMUNE SYSTEM 11-JAN-02 1IT9 TITLE CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED TITLE 2 VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB FRAGMENT; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HUMANIZED ANTIBODY HFE7A, HEAVY CHAIN; COMPND 8 CHAIN: H; COMPND 9 FRAGMENT: FAB FRAGMENT; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: ,; SOURCE 6 EXPRESSION_SYSTEM: CHLOROCEBUS AETHIOPS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: AFRICAN GREEN MONKEY; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9534; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: COS-1; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PEE; SOURCE 12 OTHER_DETAILS: HUMANIZED MOUSE; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 15 ORGANISM_COMMON: MOUSE; SOURCE 16 ORGANISM_TAXID: 10090; SOURCE 17 STRAIN: ,; SOURCE 18 EXPRESSION_SYSTEM: CHLOROCEBUS AETHIOPS; SOURCE 19 EXPRESSION_SYSTEM_COMMON: AFRICAN GREEN MONKEY; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 9534; SOURCE 21 EXPRESSION_SYSTEM_CELL_LINE: COS-1; SOURCE 22 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 23 EXPRESSION_SYSTEM_PLASMID: PEE; SOURCE 24 OTHER_DETAILS: HUMANIZED MOUSE KEYWDS IMMUNOGLOBULIN, FAB, ANTI_FAS, AGONISTIC_ANTIBODY, APOPTOSIS, KEYWDS 2 ANTIBODY_HUMANIZATION, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.ITO,T.TAKAYAMA,H.HANZAWA,T.TAKAHASHI,K.MIYADAI,N.SERIZAWA,T.HATA, AUTHOR 2 H.HARUYAMA REVDAT 5 10-APR-24 1IT9 1 SOURCE REVDAT 4 27-DEC-23 1IT9 1 REMARK REVDAT 3 25-DEC-19 1IT9 1 SOURCE REVDAT 2 24-FEB-09 1IT9 1 VERSN REVDAT 1 25-FEB-03 1IT9 0 JRNL AUTH H.HARUYAMA,S.ITO,K.MIYADAI,T.TAKAHASHI,R.KAWAIDA,T.TAKAYAMA, JRNL AUTH 2 H.HANZAWA,T.HATA,J.YAMAGUCHI,H.YOSHIDA-KATO,K.ICHIKAWA, JRNL AUTH 3 J.OHSUMI,S.YONEHARA,N.SERIZAWA JRNL TITL HUMANIZATION OF THE MOUSE ANTI-FAS ANTIBODY HFE7A AND JRNL TITL 2 CRYSTAL STRUCTURE OF THE HUMANIZED HFE7A FAB FRAGMENT JRNL REF BIOL.PHARM.BULL. V. 25 1537 2002 JRNL REFN ISSN 0918-6158 JRNL PMID 12499636 JRNL DOI 10.1248/BPB.25.1537 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.ITO,T.TAKAYAMA,H.HANZAWA,T.TAKAHASHI,K.MIYADAI,N.SERIZAWA, REMARK 1 AUTH 2 H.HARUYAMA,T.HATA REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY STUDIES OF THE FAB REMARK 1 TITL 2 FRAGMENT FROM A HUMANIZED VERSION OF THE MOUSE ANTI-HUMAN REMARK 1 TITL 3 FAS ANTIBODY HFE7A REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH S.ITO,T.TAKAYAMA,H.HANZAWA,K.ICHIKAWA,J.OHSUMI,N.SERIZAWA, REMARK 1 AUTH 2 T.HATA,H.HARUYAMA REMARK 1 TITL CRYSTAL STRUCTURE OF THE ANTIGEN-BINDING FRAGMENT OF REMARK 1 TITL 2 APOPTOSIS-INDUCING MOUSE ANTI-HUMAN FAS MONOCLONAL ANTIBODY REMARK 1 TITL 3 HFE7A REMARK 1 REF J.BIOCHEM.(TOKYO) V. 131 137 2002 REMARK 1 REFN ISSN 0021-924X REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.0 REMARK 3 NUMBER OF REFLECTIONS : 11089 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1144 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1399 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE : 0.3250 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 12.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 178 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3313 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 6 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.41 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 30.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.550 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.840 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.590 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.300 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.060 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1IT9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-JAN-02. REMARK 100 THE DEPOSITION ID IS D_1000005258. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-99 REMARK 200 TEMPERATURE (KELVIN) : 296 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : DIFFRACTOMETER REMARK 200 DETECTOR MANUFACTURER : WEISSENBERG REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12285 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.31400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, SODIUM ACETATE, METHANOL, PH REMARK 280 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.18250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.46700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.37300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.46700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.18250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.37300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP L 30 -168.09 -127.06 REMARK 500 TYR L 31 109.14 163.35 REMARK 500 LEU L 51 -63.69 -108.88 REMARK 500 ALA L 55 -26.45 66.01 REMARK 500 SER L 56 14.39 -150.50 REMARK 500 PRO L 63 166.97 -49.46 REMARK 500 ALA L 88 -156.64 -175.45 REMARK 500 SER L 95 29.64 -142.05 REMARK 500 ARG L 112 -156.55 -134.82 REMARK 500 VAL L 114 138.91 -38.46 REMARK 500 SER L 125 175.70 -59.63 REMARK 500 ASN L 142 90.74 5.56 REMARK 500 PRO L 145 -156.62 -65.76 REMARK 500 ASN L 156 -143.28 64.11 REMARK 500 ALA L 157 -32.08 -26.97 REMARK 500 LEU L 158 77.75 -65.46 REMARK 500 LYS L 173 -40.76 -153.28 REMARK 500 SER L 175 40.71 37.14 REMARK 500 LYS L 192 -18.04 -161.12 REMARK 500 GLN H 62 -15.51 -40.19 REMARK 500 LYS H 67 -41.68 -133.53 REMARK 500 ASP H 90 0.63 -63.28 REMARK 500 ASN H 104 -15.74 67.53 REMARK 500 THR H 124 77.50 -56.22 REMARK 500 LEU H 132 73.31 -104.50 REMARK 500 SER H 135 -161.91 72.34 REMARK 500 SER H 136 34.97 178.64 REMARK 500 LYS H 137 70.94 82.90 REMARK 500 THR H 139 -102.83 9.15 REMARK 500 SER H 140 99.11 14.64 REMARK 500 LEU H 146 -151.84 -121.47 REMARK 500 ASP H 152 114.08 52.63 REMARK 500 PHE H 154 137.36 -174.96 REMARK 500 PRO H 155 -153.55 -94.81 REMARK 500 SER H 164 90.48 53.88 REMARK 500 ALA H 166 3.81 -176.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IQW RELATED DB: PDB REMARK 900 1IQW CONTAINS FAB FRAGMENT OF THE MOUSE ANTI-HUMAN FAS ANTIBODY REMARK 900 HFE7A DBREF 1IT9 L 1 214 UNP Q6GMV9 Q6GMV9_HUMAN 21 231 DBREF 1IT9 H 25 219 UNP Q6PJA4 Q6PJA4_HUMAN 44 238 SEQRES 1 L 214 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 L 214 SER PRO GLY GLU ARG ALA THR LEU SER CYS LYS ALA SER SEQRES 3 L 214 GLN SER VAL ASP TYR ASP GLY ASP SER TYR MET ASN TRP SEQRES 4 L 214 TYR GLN GLN LYS PRO GLY GLN ALA PRO ARG LEU LEU ILE SEQRES 5 L 214 TYR ALA ALA SER ASN LEU GLU SER GLY ILE PRO ASP ARG SEQRES 6 L 214 PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU THR SEQRES 7 L 214 ILE SER ARG LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR SEQRES 8 L 214 CYS GLN GLN SER ASN GLU ASP PRO ARG THR PHE GLY GLN SEQRES 9 L 214 GLY THR LYS LEU GLU ILE LYS ARG THR VAL ALA ALA PRO SEQRES 10 L 214 SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SEQRES 11 L 214 SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE SEQRES 12 L 214 TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN SEQRES 13 L 214 ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR GLU SEQRES 14 L 214 GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER THR SEQRES 15 L 214 LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL SEQRES 16 L 214 TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER PRO SEQRES 17 L 214 VAL THR LYS SER PHE ASN SEQRES 1 H 219 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 H 219 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 H 219 TYR THR PHE THR SER TYR TRP MET GLN TRP VAL LYS GLN SEQRES 4 H 219 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY GLU ILE ASP SEQRES 5 H 219 PRO SER ASP SER TYR THR ASN TYR ASN GLN LYS PHE LYS SEQRES 6 H 219 GLY LYS ALA THR LEU THR VAL ASP THR SER THR SER THR SEQRES 7 H 219 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 H 219 ALA VAL TYR TYR CYS ALA ARG ASN ARG ASP TYR SER ASN SEQRES 9 H 219 ASN TRP TYR PHE ASP VAL TRP GLY GLU GLY THR LEU VAL SEQRES 10 H 219 THR VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE SEQRES 11 H 219 PRO LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR SEQRES 12 H 219 ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU SEQRES 13 H 219 PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER SEQRES 14 H 219 GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY SEQRES 15 H 219 LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SEQRES 16 H 219 SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS SEQRES 17 H 219 LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL FORMUL 3 HOH *6(H2 O) HELIX 1 1 GLU L 83 PHE L 87 5 5 HELIX 2 2 GLU L 127 GLY L 132 1 6 HELIX 3 3 LYS L 187 GLU L 191 1 5 HELIX 4 4 THR H 28 TYR H 32 5 5 HELIX 5 5 ARG H 87 THR H 91 5 5 HELIX 6 6 SER H 194 GLY H 198 1 5 SHEET 1 A 4 LEU L 4 SER L 7 0 SHEET 2 A 4 ALA L 19 ALA L 25 -1 O LYS L 24 N THR L 5 SHEET 3 A 4 ASP L 74 ILE L 79 -1 O PHE L 75 N CYS L 23 SHEET 4 A 4 PHE L 66 SER L 71 -1 N SER L 69 O THR L 76 SHEET 1 B 6 THR L 10 LEU L 13 0 SHEET 2 B 6 THR L 106 ILE L 110 1 O GLU L 109 N LEU L 11 SHEET 3 B 6 VAL L 89 GLN L 94 -1 N TYR L 90 O THR L 106 SHEET 4 B 6 MET L 37 GLN L 42 -1 N ASN L 38 O GLN L 93 SHEET 5 B 6 ARG L 49 TYR L 53 -1 O LEU L 51 N TRP L 39 SHEET 6 B 6 ASN L 57 LEU L 58 -1 O ASN L 57 N TYR L 53 SHEET 1 C 4 SER L 118 PHE L 122 0 SHEET 2 C 4 THR L 133 PHE L 143 -1 O ASN L 141 N SER L 118 SHEET 3 C 4 TYR L 177 SER L 186 -1 O LEU L 185 N ALA L 134 SHEET 4 C 4 SER L 163 VAL L 167 -1 N SER L 166 O SER L 180 SHEET 1 D 3 LYS L 149 VAL L 154 0 SHEET 2 D 3 TYR L 196 THR L 201 -1 O GLU L 199 N GLN L 151 SHEET 3 D 3 VAL L 209 PHE L 213 -1 O VAL L 209 N VAL L 200 SHEET 1 E 4 GLN H 3 GLN H 6 0 SHEET 2 E 4 SER H 17 SER H 25 -1 O LYS H 23 N VAL H 5 SHEET 3 E 4 THR H 78 SER H 84 -1 O MET H 81 N VAL H 20 SHEET 4 E 4 ALA H 68 ASP H 73 -1 N THR H 71 O TYR H 80 SHEET 1 F 5 ASN H 105 TRP H 111 0 SHEET 2 F 5 ALA H 92 TYR H 102 -1 N ARG H 98 O VAL H 110 SHEET 3 F 5 MET H 34 GLN H 39 -1 N VAL H 37 O TYR H 95 SHEET 4 F 5 LEU H 45 ASP H 52 -1 O MET H 48 N TRP H 36 SHEET 5 F 5 TYR H 57 TYR H 60 -1 O TYR H 57 N ASP H 52 SHEET 1 G 4 ASN H 105 TRP H 111 0 SHEET 2 G 4 ALA H 92 TYR H 102 -1 N ARG H 98 O VAL H 110 SHEET 3 G 4 THR H 115 VAL H 119 -1 O THR H 115 N TYR H 94 SHEET 4 G 4 GLU H 10 LYS H 12 1 N GLU H 10 O LEU H 116 SHEET 1 H 3 VAL H 171 LEU H 178 0 SHEET 2 H 3 TYR H 184 PRO H 193 -1 O SER H 185 N VAL H 177 SHEET 3 H 3 THR H 143 ALA H 145 -1 N ALA H 144 O VAL H 192 SHEET 1 I 4 VAL H 171 LEU H 178 0 SHEET 2 I 4 TYR H 184 PRO H 193 -1 O SER H 185 N VAL H 177 SHEET 3 I 4 CYS H 148 LYS H 151 -1 N CYS H 148 O SER H 188 SHEET 4 I 4 SER H 128 PRO H 131 -1 N PHE H 130 O LEU H 149 SHEET 1 J 3 THR H 159 TRP H 162 0 SHEET 2 J 3 ILE H 203 HIS H 208 -1 O ASN H 205 N SER H 161 SHEET 3 J 3 THR H 213 LYS H 218 -1 O THR H 213 N HIS H 208 SSBOND 1 CYS L 23 CYS L 92 1555 1555 2.03 SSBOND 2 CYS L 138 CYS L 198 1555 1555 2.03 SSBOND 3 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 4 CYS H 148 CYS H 204 1555 1555 2.03 CISPEP 1 SER L 7 PRO L 8 0 -0.14 CISPEP 2 ASP L 98 PRO L 99 0 -0.03 CISPEP 3 TYR L 144 PRO L 145 0 -0.26 CISPEP 4 PHE H 154 PRO H 155 0 -0.14 CISPEP 5 GLU H 156 PRO H 157 0 -0.33 CRYST1 54.365 82.746 104.934 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018394 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012085 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009530 0.00000